U.S. Insurance Stock News

NYSE:MRSH
NYSE:MRSHInsurance

Is Marsh & McLennan (MRSH) Offering Value After A 22.7% One-Year Share Price Slide?

Wondering whether Marsh & McLennan Companies at around US$176 a share is offering value or asking too much is exactly the question this breakdown aims to help you think through. The stock has slipped by 3.3% year to date and 22.7% over the last year, even though it is 58.2% higher over five years and 15.1% higher over three years, so the current price sits against a mixed return backdrop. Recent coverage has focused on Marsh & McLennan Companies as a major global insurance broker and risk...
NYSE:PSX
NYSE:PSXOil and Gas

A Look At Phillips 66 (PSX) Valuation After New Board Appointments

Phillips 66 (PSX) has drawn fresh attention after appointing Howard Ungerleider and Kevin Meyers to its Board of Directors. This governance move brings additional energy and chemicals experience into the boardroom. See our latest analysis for Phillips 66. The board refresh comes as momentum in the shares has been strong, with a 30 day share price return of 11.48% and a 90 day gain of 36.14%, contributing to a 1 year total shareholder return of 44.96%. If you are looking for other energy...
NYSE:LMND
NYSE:LMNDInsurance

Assessing Lemonade (LMND) Valuation After Recent Share Price Swings And Growth Narrative

Recent performance and why Lemonade is back on investor radars Lemonade (LMND) has drawn fresh attention after a mixed run in the stock, with gains over the past week but negative moves over the past month and past 3 months prompting closer scrutiny from investors. See our latest analysis for Lemonade. At a share price of US$64.18, Lemonade’s recent 7 day share price return of 16.37% contrasts with weaker 30 day and 90 day share price returns. Long term total shareholder returns over 1 and 3...
NYSE:AU
NYSE:AUMetals and Mining

AngloGold Ashanti (NYSE:AU) Valuation Check After Mining Stock Sell-Off On Weak Gold Silver And Copper Prices

AngloGold Ashanti stock reaction to commodity sell-off Mining stocks sold off after gold and silver hit six week lows and copper touched a three month low, and AngloGold Ashanti (NYSE:AU) dropped more than 7%, standing out among the session’s weakest S&P 500 names. See our latest analysis for AngloGold Ashanti. That sharp one day share price decline sits on top of a 15.7% 7 day and 26.2% 30 day share price fall, yet the 1 year total shareholder return of about 136% and 5 year total...
NYSE:ANF
NYSE:ANFSpecialty Retail

Assessing Abercrombie & Fitch (ANF) Valuation After Recent Share Price Volatility

Abercrombie & Fitch (ANF) has drawn attention after recent trading left the share price around $87.98, with returns under pressure in the past 3 months and year to date despite a positive 1 year total return. See our latest analysis for Abercrombie & Fitch. Short term share price momentum has faded, with a 7 day share price return of 7.48% sitting against a 30 day decline of 8.05% and a 90 day decline of 27.33%. At the same time, the 3 year total shareholder return of about 2.6x still...
NasdaqGS:ARCB
NasdaqGS:ARCBTransportation

ArcBest Climate Vote Puts Board Priorities And Valuation In Focus

ArcBest's board is urging shareholders to vote against a climate related proposal ahead of the upcoming annual meeting. The proposal calls for the company to set greenhouse gas emission reduction targets. The board's stance highlights tension between management and some shareholders over environmental priorities and disclosure. ArcBest (NasdaqGS:ARCB) enters this vote with a current share price of $87.58 and a mixed recent return profile. The stock is up 3.2% over the past week and 13.5%...
NYSE:MRK
NYSE:MRKPharmaceuticals

Assessing Merck (MRK) Valuation As Recent Share Momentum Cools

Merck stock moves and what investors may want to watch Merck (MRK) has seen mixed share performance recently, with a small 1 day decline, a 1 week pullback, and a larger move lower over the past month, alongside a gain over the past 3 months. See our latest analysis for Merck. At a share price of US$114.18, Merck’s recent 6.2% 1 month share price decline contrasts with its 7.3% year to date share price return and 27.1% 1 year total shareholder return. This suggests momentum has cooled after a...
NYSE:UAMY
NYSE:UAMYMetals and Mining

United States Antimony (UAMY) Revenue Surge Tests Bullish Growth Narratives Against Ongoing Losses

United States Antimony (UAMY) has just reported its FY 2025 numbers, with Q4 revenue of about US$13.0 million and a basic EPS loss of roughly US$0.002. Trailing 12 month figures show revenue at around US$39.3 million and a basic EPS loss of about US$0.035. Over the past six reported quarters, revenue has moved from roughly US$2.6 million in Q3 2024 to US$13.0 million in Q4 2025, with quarterly EPS ranging between a profit of about US$0.0048 and a loss of roughly US$0.039. This sets up a...
NasdaqCM:PCT
NasdaqCM:PCTChemicals

A Look At PureCycle Technologies (PCT) Valuation After Recent Share Price Gains

Context for PureCycle Technologies Stock PureCycle Technologies (PCT) has been drawing attention after recent trading in its shares, with the stock closing at US$5.79 and the company reporting US$8.355 million in revenue and a net loss of US$182.565 million. See our latest analysis for PureCycle Technologies. At a share price of US$5.79, PureCycle Technologies has seen a 1 month share price return of 37.41% and a year to date share price return of 35.31%. The 5 year total shareholder return...
NYSE:GME
NYSE:GMESpecialty Retail

GameStop CEO Ryan Cohen Puts Board Accountability In Investor Focus

GameStop (NYSE:GME) CEO Ryan Cohen has publicly criticized corporate boards for weak oversight and misaligned incentives. He has called for stronger accountability standards across corporate America, with a focus on board responsibility to shareholders. These comments come as GameStop continues to attract attention beyond its core video game retail business and ongoing transformation efforts. For investors following NYSE:GME, Cohen's remarks add a new angle to the story, one that is less...
NasdaqGS:WERN
NasdaqGS:WERNTransportation

A Look At Werner Enterprises (WERN) Valuation After Recent Share Price Weakness

Why Werner Enterprises Stock Is Back on Investors’ Radar Werner Enterprises (WERN) has drawn fresh attention after a tough month for the stock, with the share price moving lower while investors reassess the company’s trucking and logistics exposure across the United States, Mexico and Canada. See our latest analysis for Werner Enterprises. The recent slide in Werner’s share price, including a 30 day share price return of 21.66% decline and a 1 year total shareholder return of 6.31% loss,...
NYSE:GMED
NYSE:GMEDMedical Equipment

Is It Time To Reassess Globus Medical (GMED) After Its Recent 17% One-Year Gain?

If you are wondering whether Globus Medical's current share price reflects its true worth, the key pieces of the valuation puzzle can help you frame that decision. The stock last closed at US$86.26, with returns of 1.8% over 7 days, a 4.3% decline over 30 days, a 1.2% decline year to date, and a 17.2% gain over the past year. This gives you a mix of short term softness and longer term strength to think about. Recent attention around Globus Medical has focused on its role in the medical...
NasdaqGM:GCT
NasdaqGM:GCTRetail Distributors

GigaCloud Otto Group Pact Expands European Reach For Undervalued Stock

GigaCloud Technology (NasdaqGM:GCT) announced a partnership with Otto Group, one of Europe’s largest ecommerce platforms. The agreement allows select suppliers from GigaCloud’s network to offer products on Otto Group’s marketplace. The collaboration focuses on bringing furniture brands and suppliers into key European ecommerce channels. GigaCloud Technology operates a B2B ecommerce platform, connecting suppliers and resellers of large parcel goods such as furniture. By linking its supplier...
NasdaqGM:FLY
NasdaqGM:FLYAerospace & Defense

Firefly Aerospace (FLY) Narrows Quarterly Losses Challenging Skeptics On Profitability Path

Firefly Aerospace (FLY) just closed FY 2025 with fourth quarter revenue of US$57.7 million and a basic EPS loss of US$0.26, alongside trailing twelve month revenue of US$159.9 million and a TTM EPS loss of US$4.83, versus very large revenue growth of 163% over the past year. Over recent quarters, the company has seen revenue move from US$9.0 million in Q4 2024 to US$57.7 million in Q4 2025 while quarterly basic EPS losses shifted from US$7.86 to US$0.26. This leaves investors weighing robust...
NYSE:CTVA
NYSE:CTVAChemicals

Is It Too Late To Consider Corteva (CTVA) After Its Strong Share Price Run?

Wondering if Corteva at around US$77 a share still offers value or if most of the upside is already reflected in the price? This article breaks that question down in plain terms. The stock has seen a 14.1% return year to date and 26.5% over the last year, with a recent 2.4% decline over the past week and a 1.0% return over the last 30 days, which can leave investors unsure if this is a temporary pause or a shift in sentiment. Recent coverage has focused on Corteva's position as a major...
NYSE:MKC
NYSE:MKCFood

McCormick Weighs Transformational Unilever Foods Deal And Investor Trade Offs

McCormick (NYSE:MKC) is in advanced talks with Unilever about acquiring or merging with Unilever’s entire food business. The potential deal would include major brands such as Hellmann’s and Knorr. This would be the largest transaction in McCormick’s history and could significantly reshape its global presence. McCormick is already a major player in spices, seasonings, and flavor solutions, and Unilever’s food division brings household names in sauces, soups, and meal products. For readers...
NasdaqGM:LUNR
NasdaqGM:LUNRAerospace & Defense

Did Intuitive Machines’ (LUNR) Bold 2026 Near‑$1 Billion Revenue Target Just Redefine Its Risk Profile?

Earlier this week, Intuitive Machines, Inc. reported fourth-quarter 2025 revenue of US$44.79 million and a net loss of US$39.88 million, alongside full-year 2025 revenue of US$210.06 million and a net loss of US$83.29 million, while issuing 2026 revenue guidance of US$900 million to US$1 billion. Alongside weaker-than-expected quarterly results, the company underscored a rapid shift in scale through acquisitions such as Lanteris Space Systems and a growing portfolio of long-term NASA and...
NasdaqGS:DOCU
NasdaqGS:DOCUSoftware

Assessing DocuSign (DOCU) Valuation After Recent Mixed Share Performance

DocuSign (DOCU) is drawing fresh investor attention after a period of mixed share performance, including gains over the past month but weaker returns over the past 3 months and year. See our latest analysis for DocuSign. At around $47.23 per share, DocuSign has seen a 5.38% 1 month share price return but a weaker 32.51% 3 month share price return and a 46.37% 1 year total shareholder return decline, suggesting recent momentum is tentative after a tougher longer term stretch. If DocuSign's...
NasdaqGS:FSUN
NasdaqGS:FSUNBanks

Is It Time To Revisit FirstSun Capital Bancorp (FSUN) After Recent Share Price Weakness

If you are wondering whether FirstSun Capital Bancorp at US$35.51 is priced attractively or already reflects its quality, a good starting point is to look closely at what the current valuation is actually telling you. The stock has been fairly active, with a 1.9% move over the last 7 days, a 9.5% decline over the last 30 days, and returns of 6.1% decline year to date and 6.7% decline over the last year, while still sitting on a 25.9% gain across the last 3 years. Recent coverage of regional...
NasdaqGS:CART
NasdaqGS:CARTConsumer Retailing

Is It Time To Reconsider Maplebear (CART) After Recent Share Price Swings?

Wondering whether Maplebear at around US$36.93 is a bargain or just fairly priced? This article walks you through what the current numbers suggest about its value. The stock has been choppy, with a 3.8% return over the last 30 days, a 7 day return of a 3.4% decline, and a 1 year return of a 5.1% decline. This may hint at shifting expectations around both growth potential and risk. Recent coverage has focused on Maplebear as investors reassess consumer retail names in light of changing...
NasdaqGS:LCID
NasdaqGS:LCIDAuto

Lucid Expands Beyond Luxury Sedans With Midsize EV And Robotaxi Plan

Lucid Group (NasdaqGS:LCID) used its investor day to unveil a new midsize EV platform aimed at more accessible models. The company introduced its Atlas electric drive unit and previewed a proprietary two-seat robotaxi concept. Lucid outlined a multi-pronged commercialization plan, including mobility service partnerships and a target to reach positive cash flow by the end of the decade. Lucid Group, known for its premium electric sedans, is moving beyond its initial luxury niche as midsize...
NYSE:COR
NYSE:CORHealthcare

Is It Time To Reassess Cencora (COR) After The Recent Share Price Pullback

Investors may be wondering whether Cencora's share price still offers value after a strong run, or if most of the upside is already in the rear-view mirror. The stock last closed at US$326.91, with a 7 day return of a 6.6% decline and a 30 day return of a 9.2% decline, while the 1 year return stands at 23.1% and the 3 year and 5 year returns are 114.6% and 190.3% respectively. Recent news around Cencora has focused on its role as a major healthcare distributor and how investors interpret...
NasdaqGS:GRAB
NasdaqGS:GRABTransportation

Assessing Grab Holdings (NasdaqGS:GRAB) Valuation As Shares Deliver Mixed Recent Returns

What recent performance says about Grab Holdings (GRAB) Grab Holdings (NasdaqGS:GRAB) has drawn fresh attention after a period of weaker share performance, including a month return of 20% and a past 3 months return of 27.8%. In this context, investors are weighing the company’s US$3,370.0 million revenue, US$268.0 million net income, and its current US$3.56 share price when thinking about risk and potential reward. See our latest analysis for Grab Holdings. At the current US$3.56 share price,...
NasdaqGS:GIII
NasdaqGS:GIIILuxury

A Look At G III Apparel Group (GIII) Valuation After Weak Q4 Results And Lower Forward Guidance

Why G-III’s latest quarter matters for shareholders G-III Apparel Group (GIII) is back in focus after fourth quarter results showed a shortfall in revenue and a sharp operating margin contraction, tied to license exits and a Saks related bad debt expense. Management also issued guidance pointing to lower net sales and earnings for upcoming periods versus the prior year, while highlighting ongoing cost pressures and a move toward prioritizing owned brands, which together help frame current...